BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34619137)

  • 21. Facility volume and postoperative outcomes for malignant pleural mesothelioma: A National Cancer Data Base analysis.
    Verma V; Ahern CA; Berlind CG; Lindsay WD; Grover S; Culligan MJ; Friedberg JS; Simone CB
    Lung Cancer; 2018 Jun; 120():7-13. PubMed ID: 29748018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complications and Predictive Factors for Air Leak > 10 Days with Neoadjuvant Chemotherapy Followed by Pleurectomy/Decortication for Malignant Pleural Mesothelioma.
    Nakamura A; Kondo N; Nakamichi T; Hashimoto M; Takuwa T; Matsumoto S; Kuribayashi K; Kijima T; Hasegawa S
    Ann Surg Oncol; 2021 Jun; 28(6):3057-3065. PubMed ID: 33123856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved Outcomes with Modern Lung-Sparing Trimodality Therapy in Patients with Malignant Pleural Mesothelioma.
    Shaikh F; Zauderer MG; von Reibnitz D; Wu AJ; Yorke ED; Foster A; Shi W; Zhang Z; Adusumilli PS; Rosenzweig KE; Krug LM; Rusch VW; Rimner A
    J Thorac Oncol; 2017 Jun; 12(6):993-1000. PubMed ID: 28341225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical strategy for malignant pleural mesothelioma: the superiority of pleurectomy/decortication.
    Kanayama M; Mori M; Matsumiya H; Taira A; Shinohara S; Takenaka M; Kuroda K; Tanaka F
    Surg Today; 2022 Jul; 52(7):1031-1038. PubMed ID: 35044520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term outcomes and risk factors of residual thoracic spaces after pleurectomy/decortication for mesothelioma.
    Nakamura A; Hashimoto M; Kondo N; Matsumoto S; Nakamichi T; Kuribayashi K; Kijima T; Kodama H; Yamakado K; Hasegawa S
    Eur J Cardiothorac Surg; 2022 Dec; 63(1):. PubMed ID: 36259940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-incisional pleurectomy-decortication for malignant pleural mesothelioma.
    Tanaka F; Imanishi N; Takenaka M; Taira A
    Surg Today; 2018 Jun; 48(6):656-658. PubMed ID: 29492684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathological features of radiological early malignant pleural mesothelioma with no apparent tumor or pleural thickening.
    Nakamura A; Hashimoto M; Kodama H; Yuki M; Kondo N; Yamakado K; Tsujimura T; Kijima T; Hasegawa S
    Int J Clin Oncol; 2021 Jan; 26(1):95-103. PubMed ID: 32914367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The management of the diaphragm during radical surgery for malignant pleural mesothelioma.
    Sharkey AJ; Bilancia R; Tenconi S; Nakas A; Waller DA
    Eur J Cardiothorac Surg; 2016 Aug; 50(2):311-6. PubMed ID: 27005974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Updated meta-analysis of survival after extrapleural pneumonectomy versus pleurectomy/decortication in mesothelioma.
    Magouliotis DE; Tasiopoulou VS; Athanassiadi K
    Gen Thorac Cardiovasc Surg; 2019 Mar; 67(3):312-320. PubMed ID: 30374811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of Malignant Pleural Mesothelioma in the Elderly Population.
    Verma V; Wegner RE; Ludmir EB; Hasan S; Colonias A; Grover S; Friedberg JS; Simone CB
    Ann Surg Oncol; 2019 Aug; 26(8):2357-2366. PubMed ID: 31011908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specimen weight and volume: important predictors of survival in malignant pleural mesothelioma.
    Kircheva DY; Husain AN; Watson S; Kindler HL; Durkin A; Vigneswaran WT
    Eur J Cardiothorac Surg; 2016 Jun; 49(6):1642-7. PubMed ID: 26802143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pleurectomy/decortication and hyperthermic intrapleural chemotherapy for malignant pleural mesothelioma: initial experience.
    Migliore M; Calvo D; Criscione A; Palmucci S; Fuccio Sanzà G; Caltabiano R; Spatola C; Privitera G; Aiello MM; Parra HS; Ciancio N; Di Maria G
    Future Oncol; 2015; 11(24 Suppl):19-22. PubMed ID: 26638918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.
    Flores RM; Pass HI; Seshan VE; Dycoco J; Zakowski M; Carbone M; Bains MS; Rusch VW
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):620-6, 626.e1-3. PubMed ID: 18329481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of long-term survival following radical surgery for malignant pleural mesothelioma.
    Nakas A; Waller D
    Eur J Cardiothorac Surg; 2014 Sep; 46(3):380-5; discussion 385. PubMed ID: 24482386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphangitic carcinomatosis: A common radiographic manifestation of local failure following extended pleurectomy/decortication in patients with malignant pleural mesothelioma.
    Berger I; Cengel KA; Simone CB; Alley EW; Roshkovan L; Haas AR; Patel AM; Khalid U; Culligan MJ; McNulty S; Singhal S; Friedberg JS; Katz SI
    Lung Cancer; 2019 Jun; 132():94-98. PubMed ID: 31097101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival results in biphasic malignant pleural mesothelioma patients: A multicentric analysis.
    Lococo F; Torricelli F; Lang-Lazdunski L; Veronesi G; Rena O; Paci M; Casadio C; Piana S; Novellis P; Di Stefano TS; Ciarrocchi A; Billè A
    J Thorac Cardiovasc Surg; 2020 Apr; 159(4):1584-1593.e2. PubMed ID: 31590954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amount of Epithelioid Differentiation Is a Predictor of Survival in Malignant Pleural Mesothelioma.
    Vigneswaran WT; Kircheva DY; Ananthanarayanan V; Watson S; Arif Q; Celauro AD; Kindler HL; Husain AN
    Ann Thorac Surg; 2017 Mar; 103(3):962-966. PubMed ID: 27765170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radical Radiation Therapy After Lung-Sparing Surgery for Malignant Pleural Mesothelioma: Survival, Pattern of Failure, and Prognostic Factors.
    Minatel E; Trovo M; Bearz A; Di Maso M; Baresic T; Drigo A; Barresi L; Furlan C; Del Conte A; Bruschi G; Fontana P; Pagan V; Franchin G
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):606-13. PubMed ID: 26281826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interim results of pleurectomy/decortication and intraoperative intrapleural hyperthermic cisplatin perfusion for patients with malignant pleural mesothelioma intolerable to extrapleural pneumonectomy.
    Ishibashi H; Kobayashi M; Takasaki C; Okubo K
    Gen Thorac Cardiovasc Surg; 2015 Jul; 63(7):395-400. PubMed ID: 25750109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malignant pleural mesothelioma and the Society of Thoracic Surgeons Database: an analysis of surgical morbidity and mortality.
    Burt BM; Cameron RB; Mollberg NM; Kosinski AS; Schipper PH; Shrager JB; Vigneswaran WT
    J Thorac Cardiovasc Surg; 2014 Jul; 148(1):30-5. PubMed ID: 24726744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.